This topic contains a solution. Click here to go to the answer

Author Question: Preferential agreements A) are the same as free trade agreements. B) provide market access ... (Read 104 times)

Collmarie

  • Hero Member
  • *****
  • Posts: 569
Preferential agreements
 
  A) are the same as free trade agreements.
  B) provide market access without demanding reciprocation.
  C) are not recognized under WTO rules.
  D) must be approved by the IMF.

Question 2

Which of the following is an example escape clause relief?
 
  A) A tariff is granted because foreign firms are selling below cost.
  B) A temporary tariff is granted to allow for adjustment of the domestic industry.
  C) A tariff is granted to an industry because foreign firms are subsidized by their governments.
  D) A tariff is granted to an industry because another nation persistently uses unfair trade practices.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

angrybirds13579

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

B

Answer to Question 2

B




Collmarie

  • Member
  • Posts: 569
Reply 2 on: Jun 30, 2018
Gracias!


coreycathey

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Excellent

 

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library